• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.基于免疫评分的铁死亡相关基因作为肝细胞癌患者预后标志物的鉴定与验证
J Gastrointest Oncol. 2021 Oct;12(5):2345-2360. doi: 10.21037/jgo-21-237.
2
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.免疫与铁死亡相关生物标志物特征的综合分析以改善肝细胞癌的预后预测
Front Genet. 2020 Dec 18;11:614888. doi: 10.3389/fgene.2020.614888. eCollection 2020.
3
Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.鉴定肝细胞癌铁死亡相关分子模型和免疫亚型,以实现个体化治疗。
Cancer Med. 2023 Jan;12(2):2134-2147. doi: 10.1002/cam4.5032. Epub 2022 Jul 16.
4
Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.基于铁死亡和 EMT 状态的肝细胞癌预后预测和免疫浸润分析。
Front Immunol. 2022 Dec 15;13:1076045. doi: 10.3389/fimmu.2022.1076045. eCollection 2022.
5
Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.用于预测肝细胞癌预后和免疫活性的包含mRNA和lncRNA的铁死亡相关特征模型的鉴定
Front Oncol. 2021 Sep 9;11:738477. doi: 10.3389/fonc.2021.738477. eCollection 2021.
6
Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.用于预测肝细胞癌预后、免疫治疗及药物敏感性的铁死亡和铜死亡预后特征:基于TCGA和ICGC数据库的构建与验证
Transl Cancer Res. 2023 Jan 30;12(1):46-64. doi: 10.21037/tcr-22-2203. Epub 2022 Dec 19.
7
Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.肝细胞癌中与铁死亡相关的枢纽基因:预后特征、免疫相关性及耐药性分析
Front Genet. 2022 Jul 22;13:907331. doi: 10.3389/fgene.2022.907331. eCollection 2022.
8
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.鉴定铁死亡相关基因特征在乳腺癌患者中的预后价值。
BMC Cancer. 2021 May 31;21(1):645. doi: 10.1186/s12885-021-08341-2.
9
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.一种基于铁死亡相关基因特征的膀胱癌新型预后模型。
Front Oncol. 2021 Aug 6;11:686044. doi: 10.3389/fonc.2021.686044. eCollection 2021.
10
Identification and Validation of a Novel Tertiary Lymphoid Structures-Related Prognostic Gene Signature in Hepatocellular Carcinoma.肝细胞癌中一种新型三级淋巴结构相关预后基因特征的鉴定与验证
World J Oncol. 2024 Aug;15(4):695-710. doi: 10.14740/wjon1893. Epub 2024 Jul 5.

引用本文的文献

1
and are potential prognostic biomarker in hepatocellular carcinoma caused by HBV/HCV via lactylation.并且 通过乳酰化作用,是由乙肝病毒/丙肝病毒引起的肝细胞癌中的潜在预后生物标志物。 (原英文句子似乎成分残缺,翻译可能不太准确,你可检查下是否提供完整准确的英文内容)
Front Oncol. 2025 May 12;15:1537084. doi: 10.3389/fonc.2025.1537084. eCollection 2025.
2
Recent progress of ferroptosis in cancers and drug discovery.铁死亡在癌症与药物研发中的最新进展
Asian J Pharm Sci. 2024 Aug;19(4):100939. doi: 10.1016/j.ajps.2024.100939. Epub 2024 Jun 26.
3
Targeting ferroptosis in hepatocellular carcinoma.针对肝细胞癌中的铁死亡
Hepatol Int. 2024 Feb;18(1):32-49. doi: 10.1007/s12072-023-10593-y. Epub 2023 Oct 26.
4
The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system.巨噬细胞在肝细胞癌中的核心作用:分子亚型的定义及预后风险系统
Front Pharmacol. 2023 Aug 24;14:1228052. doi: 10.3389/fphar.2023.1228052. eCollection 2023.
5
Effect of Tertiary Lymphoid Structures on Prognosis of Patients with Hepatocellular Carcinoma and Preliminary Exploration of Its Formation Mechanism.三级淋巴结构对肝细胞癌患者预后的影响及其形成机制的初步探索
Cancers (Basel). 2022 Oct 21;14(20):5157. doi: 10.3390/cancers14205157.
6
Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.三阴性乳腺癌中一种预后性铁死亡相关基因模型的开发与验证
Front Oncol. 2022 Jun 2;12:896927. doi: 10.3389/fonc.2022.896927. eCollection 2022.
7
The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma.铁死亡相关基因在肝细胞癌中的预后意义及潜在机制
Front Genet. 2022 Apr 26;13:844624. doi: 10.3389/fgene.2022.844624. eCollection 2022.

本文引用的文献

1
miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell.miR-206-G6PD 轴调节肝癌细胞的脂肪生成和细胞生长。
Anticancer Drugs. 2021 Jun 1;32(5):508-516. doi: 10.1097/CAD.0000000000001069.
2
CLTRN, Regulated by NRF1/RAN/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway.CLTRN 通过 NRF1/RAN/DLD 蛋白复合物调控增强肝癌细胞辐射敏感性的机制研究。
Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):859-871. doi: 10.1016/j.ijrobp.2020.12.062. Epub 2021 Jan 27.
3
RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.RNA 结合蛋白 DAZAP1 通过与 SLC7A11 mRNA 相互作用促进 HCC 进展并调节铁死亡。
Exp Cell Res. 2021 Feb 1;399(1):112453. doi: 10.1016/j.yexcr.2020.112453. Epub 2020 Dec 29.
4
A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.一种用于临床预测肝细胞癌患者诊断、预后及免疫微环境的缺氧相关特征。
J Transl Med. 2020 Sep 4;18(1):342. doi: 10.1186/s12967-020-02492-9.
5
Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450.肝细胞癌:外源性代谢细胞色素 P450 的基因表达谱和调控。
Biochem Pharmacol. 2020 Jul;177:113912. doi: 10.1016/j.bcp.2020.113912. Epub 2020 Mar 13.
6
Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake.黄连素通过抑制谷氨酰胺摄取来抑制肝癌细胞生长。
Onco Targets Ther. 2019 Dec 31;12:11751-11763. doi: 10.2147/OTT.S235667. eCollection 2019.
7
Macrophages in Zebrafish Models of Liver Diseases.斑马鱼肝脏疾病模型中的巨噬细胞。
Front Immunol. 2019 Dec 4;10:2840. doi: 10.3389/fimmu.2019.02840. eCollection 2019.
8
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.调节性 T 细胞和检查点抑制在肝细胞癌中的作用。
Cancer Immunol Immunother. 2019 Dec;68(12):2055-2066. doi: 10.1007/s00262-019-02427-4. Epub 2019 Nov 13.
9
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11.放疗和免疫治疗通过协同抑制 SLC7A11 促进肿瘤脂质氧化和铁死亡。
Cancer Discov. 2019 Dec;9(12):1673-1685. doi: 10.1158/2159-8290.CD-19-0338. Epub 2019 Sep 25.
10
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.当前对肝癌免疫抑制性肿瘤微环境的认识:挑战与机遇。
Mol Cancer. 2019 Aug 29;18(1):130. doi: 10.1186/s12943-019-1047-6.

基于免疫评分的铁死亡相关基因作为肝细胞癌患者预后标志物的鉴定与验证

Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.

作者信息

Wang Jukun, Han Ke, Zhang Chao, Chen Xin, Li Yu, Zhu Linzhong, Luo Tao

机构信息

Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

出版信息

J Gastrointest Oncol. 2021 Oct;12(5):2345-2360. doi: 10.21037/jgo-21-237.

DOI:10.21037/jgo-21-237
PMID:34790397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8576212/
Abstract

BACKGROUND

Ferroptosis has been found to affect the prognosis and immunotherapy of hepatocellular carcinoma (HCC). However, the association between ferroptosis-related genes and infiltrating immune cells in tumor immune microenvironment (TIME) has not been fully elucidated. This study aimed at establishing a prediction model for the progression of HCC using ferroptosis-associated genes based on immune score.

METHODS

Transcriptomic, mutation and clinicopathological information were downloaded from TCGA and International Cancer Genome Consortium (ICGC) for this study. Construction of the prediction model was done by Lasso regression analysis. Estimation of the clustering ability of the prediction model was done by t-distributed stochastic neighbor embedding (t-SNE) and principal component analysis (PCA) analyses. Assessment of the accuracy of the prediction model was done by receiver operating characteristic (ROC) and Kaplan-Meier curves.

RESULTS

A prediction model was formulated utilizing three ferroptosis-related genes (G6PD, SAT1 and SLC1A5). The model independently predicted the overall survival (OS). Differentially expressed genes (DEGs) linked to based on Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene ontology (GO) analyses immune-associated pathways and functions. Single-sample gene set enrichment analysis (ssGSEA) strategy further confirmed the model was related to immune-associated functions as well as immune cell infiltration.

CONCLUSIONS

The three ferroptosis-associated gene-based prediction model was good at predicting the OS outcomes of HCC, improve HCC prognostication and treatment in the clinic.

摘要

背景

铁死亡已被发现影响肝细胞癌(HCC)的预后和免疫治疗。然而,铁死亡相关基因与肿瘤免疫微环境(TIME)中浸润免疫细胞之间的关联尚未完全阐明。本研究旨在基于免疫评分,利用铁死亡相关基因建立HCC进展的预测模型。

方法

本研究从TCGA和国际癌症基因组联盟(ICGC)下载了转录组学、突变和临床病理信息。通过套索回归分析构建预测模型。通过t分布随机邻域嵌入(t-SNE)和主成分分析(PCA)分析评估预测模型的聚类能力。通过受试者工作特征(ROC)和Kaplan-Meier曲线评估预测模型的准确性。

结果

利用三个铁死亡相关基因(G6PD、SAT1和SLC1A5)制定了预测模型。该模型独立预测总生存期(OS)。基于京都基因与基因组百科全书(KEGG)和基因本体(GO)分析,差异表达基因(DEG)与免疫相关途径和功能相关。单样本基因集富集分析(ssGSEA)策略进一步证实该模型与免疫相关功能以及免疫细胞浸润有关。

结论

基于三个铁死亡相关基因的预测模型擅长预测HCC的OS结果,改善临床中HCC的预后和治疗。